StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research report released on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Performance NASDAQ ABIO opened at $3.22 on Monday. ARCA biopharma has a 12 month low of $1.56 and a 12 month high […]